Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors
Condition: Malignant Tumors Intervention: Biological: EBV mRNA vaccine Sponsor: West China Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials